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Iron acquisition is vital to microbial survival and is implicated in the virulence of many of the
pathogens that reside in the cystic fibrosis (CF) lung. The multifaceted nature of iron acquisition
by both bacterial and fungal pathogens encompasses a range of conserved and speciesspecific mechanisms, including secretion of iron-binding siderophores, utilization of
siderophores from other species, release of iron from host iron-binding proteins and
haemoproteins, and ferrous iron uptake. Pathogens adapt and deploy specific systems
depending on iron availability, bioavailability of the iron pool, stage of infection and presence of
competing pathogens. Understanding the dynamics of pathogen iron acquisition has the
potential to unveil new avenues for therapeutic intervention to treat both acute and chronic CF
infections. Here, we examine the range of strategies utilized by the primary CF pathogens to
acquire iron and discuss the different approaches to targeting iron acquisition systems as an
antimicrobial strategy.

CYSTIC FIBROSIS (CF) AND THE LUNG
MICROBIOME
CF is an autosomal genetic disorder and is the most
common lethal genetic disease amongst Caucasians, with
w30000 patients currently on the European Cystic Fibrosis
Society registry and a projected increase of 50% in the
number of CF patients in the European Union by 2025
(Burgel et al., 2015). CF is caused by a defect in the CF
transmembrane conductance regulator (CFTR) gene resulting in a decreased airway surface liquid and increased
mucous viscosity in the CF lung, leading to impaired
mucociliary clearance of micro-organisms (Boucher,
2007). Due to this impairment, *90% of CF patients succumb to respiratory failure as a result of chronic bacterial
infections (Lubamba et al., 2012). Pseudomonas aeruginosa
is the pathogen of highest prevalence and incidence in the
CF lung with 50–60% of adult CF patients colonized,
followed in prevalence by Staphylococcus aureus (LiPuma,
2010). The epidemiology of CF pathogens has changed in
the last decade, and in a retrospective analysis of the data
reported to the CF Foundation Patient Registry in the
USA, the prevalence and incidence of methicillin-resistant
Staphylococcus aureus (MRSA) had significantly increased
in CF patients (Salsgiver et al., 2015). Although of much

Abbreviations: ABC, ATP-binding cassette; Bcc, Burkholderia
cepacia complex; CF, cystic fibrosis; CFEM, common fungal
extracellular membrane; CFTR, cystic fibrosis transmembrane
conductance regulator; MRSA, meticillin-resistant Staphylococcus
aureus; NRPS, non-ribosomal protein synthetase; TBDR,
TonB-dependent receptor.
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lower prevalence (v5%), Burkholderia cepacia complex
(Bcc) organisms are particularly problematic in CF due
to their transmissibility and in a subset of patients can
lead to a fulminant pneumonia with a high mortality rate
(Mahenthiralingam et al., 2005). Haemophilus influenzae
is associated with early stage CF with up to 30% of those
under 5 years colonized, compared with v10% of adult
CF patients (LiPuma, 2010). In addition to MRSA, other
emerging pathogens in CF include Achromobacter xyloxidans, Stenotrophomonas maltophilia, non-tuberculous
mycobacteria and Mycobacterium avium (Parkins & Floto,
2015; Salsgiver et al., 2015). Also represented are the
genera Streptococcus, Prevotella, Rothia, Veillonella and
Actinomyces (Coburn et al., 2015). Non-culture-based
identification methods have increased the detection of
fungi in CF, with Aspergillus fumigatus being the most frequently isolated (Sabino et al., 2015) and a decline in lung
function appears to be a risk factor for Aspergillus fumigatus, which in turn is associated with a further deterioration
in chronically colonized patients (Noni et al., 2015). Candida albicans, a frequent colonizer of the CF lung, is also
associated with a significant decline in lung function in
chronically colonized patients (Gileles-Hillel et al., 2015).
Despite the complexity of the microbiome of the CF
lung, a recent study has shown that the microbial community is stable during periods of clinical stability. However,
with the onset of clinical exacerbations, a decrease in the
dominant taxa was observed in some patients (Carmody
et al., 2015). The advent of high-throughput detection
methods to profile CF microbiota can facilitate the
rapid identification of colonizing organisms and detect
changes in microbial diversity as disease progresses
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(Flight et al., 2015), and molecular signatures of species
associated with different levels lung function may have
potential as predictive biomarkers for clinical deterioration
in CF (Paganin et al., 2015). The emerging data on changes
in the bacterial community of the CF lung are the subject of
a recent review by Caverly et al. (2015). As the complexity
and dynamic nature of the CF microbiome are being
increasingly characterized, microbiologists are continually
challenged to understand the potential of these organisms
to contribute to CF lung disease and to develop targeted
strategies against the main perpetrators.

IRON AND CF
CF pathogens, similar to other pathogenic micro-organisms, require iron for many basic cellular functions and
metabolic pathways. However, iron metabolism is tightly
regulated to prevent iron toxicity and to limit iron availability to pathogens, as recently reviewed by Ganz &
Nemeth (2015). The liver hormone hepcidin plays a key
role in iron homeostasis by causing degradation of the
iron transporter ferroportin, thereby blocking iron flow
into the plasma from cellular stores and from dietary
sources (Nemeth et al., 2004b). Hepcidin is elevated in
response to iron and also to inflammatory signals
(Nemeth et al., 2004a), and is downregulated when iron
levels are diminished (Donovan et al., 2005), thus playing
a central role in iron homeostasis. Iron is recycled from
senescent erythrocytes by macrophages and redistributed
back to the bone marrow (Beaumont & Delaby, 2009).
Coupled with maintaining iron homeostasis, the availability of iron for pathogens is tightly restricted. More
than half of the total bodily iron is bound to haemoglobin
in erythrocytes, approximately a quarter of bodily iron is
stored within cells bound to ferritin and transferrin chaperones iron in plasma (Ganz & Nemeth, 2015). These
proteins, together with other iron-sequestering proteins
including lipocalins that sequester iron from bacterial siderophores (Goetz et al., 2002; Fluckinger et al., 2004), play a
significant role in iron-targeted nutritional immunity. The
battle between host iron sequestration and Staphylococcus
aureus iron acquisition typifies these complex relationships,
and is detailed in a review by Haley & Skaar (2012).
Host iron metabolism is, however, altered during infection,
with increased levels of iron-scavenging activity by both the
host and pathogen (Parrow et al., 2013). An increase in
hepcidin in response to inflammatory mediators, including
IL-6, results in hypoferraemia, commonly associated with
inflammation (Nemeth et al., 2004a) and with a prevalence
of 62–72% in CF patients (Pond et al., 1996; Reid et al.,
2002). In a recent study of CF pulmonary exacerbation,
patients following treatment with intravenous antibiotics
had lower hepcidin and IL-6 levels in serum, increased
serum iron, and a trend towards lower sputum iron
levels – further evidence of the impact of infection and
inflammation on iron metabolism (Gifford et al., 2012).
Not surprisingly, given the inflammatory environment of
192

the CF lung, elevated levels of iron and ferritin have been
detected in CF sputum by a number of studies (Stites
et al., 1998, 1999; Reid et al., 2004, 2007; Gray et al.,
2010). More recently in a comprehensive study of iron in
CF, Ghio et al. (2013) demonstrated increased levels of
iron and iron-related proteins in bronchoalveolar lavage
fluids from CF children, in macrophages of explanted CF
lungs and in lung tissue from CF patients – clear evidence
of altered iron homeostasis and of iron accumulation in the
CF airways (Ghio et al., 2013). Consistent with these findings, Moreau-Marquis et al. (2008) demonstrated that
airway cells expressing DF508-CFTR released more
extracellular iron than cells rescued with WT-CFTR
(Moreau-Marquis et al., 2008). Furthermore, iron and
ferritin levels are positively correlated with c.f.u. of
P. aeruginosa and remain elevated after antibiotic treatment
of P. aeruginosa infection (Reid et al., 2007). Aspergillus
fumigatus co-cultured with macrophages downregulates
expression of two cellular iron importers and the iron
exporter ferroportin, which, together with an increase in
iron retention and ferritin synthesis by the exposed macrophages, provides further evidence of the impact of infection
on host iron homeostasis (Seifert et al., 2008). The majority
of the iron is associated with ferritin and in the ferric
(Fe3+) form with limited bioavailability; however, CF
pathogens have a range of mechanisms by which they can
form usable ferrous (Fe2+) iron and thereby thrive in
this niche. The acidic environment of the CF lung (Tate
et al., 2002) may limit Fe2+ oxidation, further enhancing
ferrous iron levels. Recently, Hunter et al. (2013) determined that the relative balance of ferric and ferrous iron
in the CF lung changes as infections progress and over
time ferrous iron dominates (Hunter et al., 2013).
Increased airway iron in CF therefore facilitates the colonization by pathogens having the capacity to exploit this
resource. There is a variety of evidence implicating iron
acquisition in microbial pathogenesis. Over a decade ago,
Berlutti et al. (2005) demonstrated that iron availability
impacts on biofilm formation, adhesion and invasion of
two important CF pathogens, P. aeruginosa and Burkholderia cenocepacia. More recently, Wiens et al. (2014)
demonstrated that alginate production, mucoid phenotype
and biofilm formation by P. aeruginosa are iron regulated.
In this review we examine what is currently known about
iron acquisition by the main CF pathogens and focus on
four key mechanisms: production of iron-binding siderophores, haem uptake systems, iron acquisition from host
iron-binding proteins and uptake of ferrous iron, and
then outline the potential of targeting iron acquisition in
treating CF infections.

SIDEROPHORE-MEDIATED IRON
ACQUISITION
Siderophore-mediated iron acquisition has been identified
as an important virulence factor for many CF pathogens
(Thomas, 2007; Cornelis & Dingemans, 2013). Siderophores
Microbiology 162

Iron acquisition in the CF lung

are small iron-chelating molecules secreted by Gramnegative, Gram-positive and fungal micro-organisms.
They are generally classed as catecholate-type siderophores
that bind ferric iron via hydroxyl groups, hydroxamatetype siderophores that chelate ferric iron via a carbonyl
group with an adjacent nitrogen, and mixed-type siderophores that have both catechol- and hydroxamate-binding
moieties. P. aeruginosa, the predominant pathogen in CF,
secretes two siderophores, pyoverdine and pyochelin, in
response to iron deprivation (Liu & Shokrani, 1978; Cox
& Adams, 1985; Heinrichs et al., 1991). Both pyoverdine
and pyochelin biosynthesis and uptake are regulated by
the ferric uptake regulator (Fur) protein – the primary
controller of iron regulated genes in many Gram-negative
bacteria (Ochsner et al., 2002; Michel et al., 2005). The predominant siderophore pyoverdine is a mixed-type siderophore and has a higher affinity for iron than pyochelin
(Cox & Graham, 1979). Three structurally different pyoverdines have been identified (Briskot et al., 1986) and
are the subject of a recent review (Cézard et al., 2015).
Pyoverdine plays a role in Pseudomonas pathogenesis in
animal models of infection (Meyer et al., 1996; Takase
et al., 2000; Xiong et al., 2000). Of particular relevance to
CF lung disease is the established role of this siderophore
in P. aeruginosa biofilm formation (Banin et al., 2005).
Pyochelin, a phenolate, is unusual amongst siderophores
in having neither catecholate nor hydroxamate groups,
and binds Fe3+ via the carboxylate group and the phenolic
OH group. Pyochelin is produced when iron is less
restricted and although it has a lower affinity for iron
than pyoverdine, its biosynthesis is a more energy-efficient
process (Ravel & Cornelis, 2003; Moon et al., 2008;
Cornelis, 2010; Dumas et al., 2013). P. aeruginosa has the
ability to utilize siderophores from other pseudomonads
as well as other bacterial species and fungi. P. aeruginosa
strains have w30 genes encoding TonB-dependent
receptors (TBDRs), which are involved in the uptake of
ferrisiderophores (Cornelis & Bodilis, 2009). Receptors
for mycobactin and carboxymycobactin (Llamas et al.,
2008), ferrichrome and ferrioxamine (Llamas et al., 2006;
Cuı́v et al., 2007; Hannauer et al., 2010), rhizobactin, aerobactin and schizokinen (Cuı́v et al., 2006), and vibriobactin
(Elias et al., 2011) have all been identified. Given the evidence to date, P. aeruginosa appears to have the greatest
capacity for siderophore piracy in the CF lung microbiome.
Staphylococcus aureus, one of the earlier pathogens to colonize the CF lung, produces two a-hydroxycarboxylate-type
siderophores, staphyloferrin A and staphyloferrin B, and
expression is regulated by iron through Fur (Beasley
et al., 2009). Both siderophores have unique transporters,
HtsABC (haem transport system) and SirABC (staphylococcal iron regulated), respectively (Beasley et al., 2009;
Cheung et al., 2009). Staphylococcus aureus can acquire
iron using a variety of xenosiderophores (Table 1), including hydroxamate siderophores, which itself cannot
produce, using the conserved ferric hydroxamate uptake
system Fhu (Sebulsky et al., 2003, 2004), and catecholate
http://mic.microbiologyresearch.org

xenosiderophores through the highly conserved staphylococcal siderophore ATP-binding cassette (ABC) transporter SstABCD (Beasley et al., 2011). Iron acquisition
strategies of Gram-positive pathogens including Staphylococcus aureus are the subject of a recent review by Sheldon
& Heinrichs (2015).
Members of the Bcc have the ability to produce up to four
siderophores, including ornibactin which is the predominant siderophore produced by Burkholderia strains
(Darling et al., 1998), and is an important virulence
factor for these bacteria to establish and maintain infection
(Darling et al., 1998; Sokol et al., 1999, 2000). To date,
species known to produce ornibactin under iron starvation
include Burkholderia cepacia, Burkholderia cenocepacia,
Burkholderia vietnamiensis and Burkholderia ambifaria
(Meyer et al., 1995; Thomas, 2007; Asghar et al., 2011).
More recently, ornibactin gene expression has been
reported for the first time in Burkholderia multivorans
(Denman et al., 2014). There are three known species of
this linear hydroxamate siderophore: ornibactin-C4,
ornibactin-C6 and ornibactin-C8 produced by Bcc strains
(Stephan et al., 1993), and ferrated ornibactin is transported across the outer membrane by a ferric-ornibactin
receptor, OrbA. Similar to Pseudomonas siderophore biosynthesis, the ornibactin operon is Fur regulated (Agnoli
et al., 2006). The second siderophore produced by some
strains of the Bcc is pyochelin (Sokol, 1986), and the
production of ornibactin and pyochelin correlates with
morbidity and mortality in CF (Sokol, 1986; Visser et al.,
2004). However, approximately half of Bcc clinical isolates
do not produce pyochelin (Darling et al., 1998). Cepaciachelin, a catecholate siderophore first isolated under ironlimiting growth conditions from Burkholderia ambifaria,
and cepabactin, a cyclic hydroxamate first isolated from
Burkholderia cepacia ATCC 25416, are also produced by
some members of the Bcc (Meyer et al., 1989, 1995; Darling
et al., 1998). To date very little is known about the nature
of xenosiderophore utilization by Bcc. Our recent study
demonstrated that Burkholderia cenocepacia J2315 and
three clinical isolates of Burkholderia cenocepacia cannot
utilize pyoverdine from P. aeruginosa. Even though these
isolates can produce siderophores, growth was severely
inhibited in the presence of pyoverdine, presumably due
to the high iron-binding capacity of pyoverdine over Bcc
siderophores (Tyrrell et al., 2015). Previous studies demonstrated that another member of the Bcc, Burkholderia
cepacia, is also unable to utilize pyoverdines for iron acquisition (Meyer et al., 1989). Iron acquisition by the Bcc has
been comprehensively reviewed by Thomas (2007).
Stenotrophomonas maltophilia, an emerging CF pathogen,
produces catechol-type siderophores; however, they have
not been fully characterized and their role in infection is
unknown (Garcı́a et al., 2012). Siderophore secretion by
some strains of Achromobacter xylosoxidans isolated from
soil has been reported (Tian et al., 2009); however,
no investigations of clinical isolates have been reported.
There are no reports of siderophore production by
193
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Table 1. Iron acquisition systems utilized by main CF pathogens
Bacterial species

Endogenous siderophore

P. aeruginosa

Pyoverdine
Pyochelin

S. aureus

Staphyloferrin A
Staphyloferrin B

Bcc

H. influenzae
A. fumigatus

C. albicans

NR ,

Exogenous
siderophore

Haem uptake
system

Host iron-binding
proteins

Ferrous iron
uptake system

Mycobactin
Carboxymycobactin
Ferrichrome
ferrioxamine
Rhizobactin
Aerobactin
Schizokinen
Vibriobactin
Pyoverdine
Ferrichrome
Desferrioxamine-B
Aerobactin
Coprogen

Has
Phu

Transferrin
Lactoferrin
Ferritin

Feo

Isd

Transferrin

feoABC locus

Ornibactin
Pyochelin
Cepabactin
Cepaciachelin

NR

huvA–hmuSTUV
(unconfirmed)

Transferrin
Lactoferrin
Ferritin

NR

NR

Ferrichrome (operon)
Ferrichrome
Coprogen
Ferrioxamine B
Ferrioxamine E

HpbA
NR

Transferrin

Ferrireductase FreB
Ferroxidase FetC
Permease FtrA

Fusarinine C
Triacetylfusarinine C
Ferricrocin

Rbt5/Pga7

Transferrin
Ferritin

Several ferric reductases

Fusarinine C
Triacetylfusarinine C
Ferricrocin
Hydroxyferricrocin
Hexadeydroastechrome
Hydroxamate-type
Phenolate-type
(uncharacterized)

None reported.

H. influenzae; however, comparative genomics has identified an operon for ferrichrome utilization in non-typable
H. influenzae strains (Morton et al., 2010).
The fungal pathogen Aspergillus fumigatus produces four
hydroxamate siderophores: fusarinine C and triacetylfusarinine C, which are secreted, and ferricrocin the
intracellular iron storage siderophore in hyphae and
hydroxyferricrocin the iron siderophore storage in conidial spores (Schrettl et al., 2007; Wallner et al., 2009;
Haas, 2012). An additional siderophore-like molecule
called hexadeydroastechrome was recently isolated
from Aspergillus fumigatus and increased virulence
when overexpressed in a murine model of infection
(Yin et al., 2013). There is significant evidence that
iron uptake in Aspergillus fumigatus is essential to
virulence (Moore, 2013). In particular, siderophoremediated iron acquisition is vital for Aspergillus fumigatus virulence in a murine model of invasive aspergillosis
(Schrettl et al., 2004; Hissen et al., 2005) and to
the survival of the conidia in macrophages
194

(Schrettl et al., 2010). Siderophore biosynthetic enzymes
are also upregulated in conidia internalized by airway
epithelial cells (Oosthuizen et al., 2011). Aspergillus
fumigatus has been reported to utilize xenosiderophores
including ferrichrome, coprogen, ferrioxamine B and
ferrioxamine E (Petrik et al., 2012). Candida albicans,
also a frequent colonizer in CF (Chotirmall et al.,
2010), has been reported to produce both hydroxamateand phenolate-type siderophores (Holzberg & Artis,
1983; Ismail et al., 1985); however, siderophore biosynthesis genes have not been identified in the Candida
albicans genome (Haas, 2003). Candida albicans does,
however, express a siderophore iron transporter (Sit1)
allowing it to transport and utilize ferrichrome-type
siderophores including triacetylfusarinine C and ferricrocin from Aspergillus fumigatus, and a Sit1 mutant
has reduced invasion and penetration in a human epithelium model of infection (Heymann et al., 2002),
highlighting the pivotal role of iron acquisition in
establishing Candida albicans in the CF lung.
Microbiology 162
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HAEM UPTAKE SYSTEMS
Although the majority of haem in the host is bound to
intracellular haemoproteins, primarily haemoglobin (Stojiljkovic & Perkins-Balding, 2002), free haem and haemoglobin are released by damaged cells during infection and
not surprisingly the successful CF pathogens are all adept
at utilizing this iron source. P. aeruginosa has the capacity
to take up haem from haemoproteins via two systems, Has
(haem assimilation system) and Phu (Pseudomonas haem
uptake; Ochsner et al., 2000). In the Phu system, haemoproteins bind directly to a TBDR and haem is extracted,
whereas the Has system uses a secreted haemophore to
extract haem from haemoproteins and transport it to a
TBDR, HasR. Haem, bound by a periplasmic binding protein, is transported to the cytoplasm by an ABC transporter
where it is bound to a haem chaperone, PhuS. It is
then degraded by the haem oxygenase HemO and Fe2+
is released (Wegele et al., 2004; Kaur et al., 2009).
P. aeruginosa adapts its iron acquisition strategy depending
on available iron, and the Fur protein represses the
expression of the Has and Phu systems in response to
excess iron (Cornelis & Dingemans, 2013). A recent study
demonstrates that in the CF lung, haem uptake is a critical
source of iron for P. aeruginosa during chronic infection
with more efficient utilization of haem by later compared
with earlier isolates and consistent expression of the
haemoxygenase HemO during prolonged infection
(Nguyen et al., 2014). Further evidence of this adaptive
response by P. aeruginosa is provided in a study by Marvig
et al. (2014) that demonstrated within-host evolution
towards haem utilization, coupled with loss of pyoverdine
production in three separate P. aeruginosa lineages (Marvig
et al., 2014).
Staphylococcus aureus preferentially utilizes haem as a vital
source of iron (Skaar et al., 2004b) and the iron-regulated
surface determinant (Isd) system, first described in 2002
(Mazmanian et al., 2002, 2003), is now known to involve
nine proteins. Four of these proteins (IsdB, IsdH, IsdA
and IsdC) form a complex covalently bound to peptidoglycan through which haem is delivered to an ABC transporter comprising IsdE and IsdF (Grigg et al., 2007).
Haem is degraded by the haem monooxygenases IsdG and
IsdI to release iron (Skaar et al., 2004a). Recently, Hannauer
et al. (2015) reported the involvement of two additional
reductases, NrtA and IruO, in haem iron removal by Staphylococcus aureus. The Isd-mediated haem uptake system of
Staphylococcus aureus was comprehensively reviewed by
Hammer & Skaar (2011) and its significance in Staphylococcus aureus infections is demonstrated by its requirement
for full virulence in several models of pathogenesis, as
reviewed by Grigg et al. (2010).
The haem acquisition system of Burkholderia cenocepacia is
reported to be similar to the huvA–hmuSTUV system of
Burkholderia pseudomallei (Shalom et al., 2007), with an
operon comprising five genes bhuRSTUV predicted to
encode the outer membrane haem receptor, a shuttle
http://mic.microbiologyresearch.org

protein and components of the haem permease (Thomas,
2007). We have reported the uptake of haemin by Burkholderia cenocepacia in the absence of siderophore secretion,
confirming the ability of these pathogens to exploit this
host iron source in the CF lung (Tyrrell et al., 2015).
H. influenzae, unlike the other CF pathogens, has an absolute growth requirement for haem as it cannot synthesis
protoporphyrin IX (Panek & O’Brian, 2002). The haembinding lipoprotein HpbA is required for haem utilization
from different sources (Morton et al., 2005, 2009) and is
implicated in H. influenzae virulence in animal models of
infection (Morton et al., 2009).
Much less is known about haem uptake by pathogenic
fungi compared with bacteria. The utilization of haem
by Candida albicans has been described and is mediated
by specific receptors such as Rbt5 (Weissman & Kornitzer,
2004; Okamoto-Shibayama et al., 2014). A new haembinding protein, Pga7, a member of the common fungal
extracellular membrane (CFEM) family, has recently
been reported in Candida albicans and contributes to virulence in a mouse model. In vitro, both Rbt5 and Pga7
extract haem from haemoglobin, and haem can be rapidly
transferred between these two CFEM proteins (Kuznets
et al., 2014). Candida albicans also produces the haemolytic molecule mannan which facilitates access to haembound iron (Tanaka et al., 1997; Watanabe et al., 1999).
Interestingly, Aspergillus fumigatus lacks the ability to use
haem as an iron source (Eisendle et al., 2003) and its
CFEM domain proteins do not play a role in either
haem uptake or virulence (Vaknin et al., 2014).

IRON ACQUISITION FROM HOST
IRON-BINDING PROTEINS
In the host environment iron is bound to proteins such as
ferritin, transferrin and lactoferrin to reduce free iron to
*10218 M (Bullen, 1981), and in the CF lung some of
these proteins are elevated during infection (Parrow
et al., 2013). CF pathogens have developed mechanisms
that enable them to acquire iron from host iron-binding
proteins during infection. P. aeruginosa pyoverdine and
pyochelin can displace iron from transferrin (Takase
et al., 2000). P. aeruginosa also has the ability to release
iron from transferrin using elastase (LasB; Wolz et al.,
1994), the alkaline protease AprA (Kim et al., 2006) and
the endoprotease PrpL (Wilderman et al., 2001). PrpL
can also hydrolyse lactoferrin, in addition to other extracellular host proteins, leading to tissue damage and further
contributing to the infection process (Wilderman et al.,
2001). In the CF lung transferrin and lactoferrin also
undergo proteolytic cleavage by human-derived elastases,
making iron more readily available for P. aeruginosa
(Britigan et al., 1993). Ferritin, abundant in the CF lung,
is also a source of iron for P. aeruginosa. Dehner et al.
(2013) demonstrated that P. aeruginosa can remove iron
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from ferritin and transport it into the cell independently of
siderophore production (Dehner et al., 2013).
The two Staphylococcus aureus siderophores staphyloferrin
A and staphyloferrin B are capable of liberating iron from
transferrin, which is then carried by the aforementioned
ABC transporters Hts and Sir, respectively, into the cell
(Beasley et al., 2011). It is also noteworthy in the context
of severely ill patients that stress hormones can also
facilitate pathogen removal of iron from transferrin and
lactoferrin (Freestone et al., 2008). Catecholamine stress
hormones form complexes with the ferric iron in these
host proteins, resulting in iron reduction and liberation,
facilitating enhanced bacterial growth (Sandrini et al.,
2010). In a staphyloferrin-deficient Staphylococcus aureus
strain, the catecholamine-liberated transferrin iron is transported via the Sst ABC transporter (Beasley et al., 2011).
Alternatively, Staphylococcus aureus is also reported to
release iron from transferrin by increasing the production
of lactate, resulting in acidification of the surrounding
environment (Friedman et al., 2006).
Burkholderia cenocepacia is also capable of exploiting the
ferritin iron source in the CF lung by protease cleavage
(Whitby et al., 2006). Our studies have shown that Burkholderia cenocepacia, in addition to ferritin, also has the ability
to utilize lactoferrin and transferrin when siderophore
production is unavailable (Tyrrell et al., 2015).
Despite reports of the inhibitory effects of lactoferrin and
transferrin on pathogenic fungi (Almeida et al., 2009;
Caza & Kronstad, 2013), Candida albicans and Aspergillus
fumigatus can both utilize transferrin bound iron for
growth using different mechanisms (Ramanan & Wang,
2000; Hissen et al., 2004). Siderophores are not involved
in iron acquisition by Candida albicans; rather direct contact of Candida albicans with transferrin is required. Iron is
then released from transferrin by the activity of the
reductase Fre10 and the permease Ftr1 (Ramanan &
Wang, 2000). Aspergillus fumigatus, similar to the other
CF pathogens, uses secreted siderophores to access iron
from transferrin (Hissen et al., 2004; Hissen & Moore,
2005). Ferritin use as a sole iron source for fungal pathogens has been best characterized in Candida albicans and
involves the adhesin Als3 in ferritin uptake with acidification as the probable mechanism for the release of iron
(Almeida et al., 2008).
The range of direct and indirect mechanisms used by CF
pathogens to access iron from host iron-binding proteins
illustrates their ability to exploit this iron pool and
undoubtedly facilitates their survival in the CF lung.

FERROUS IRON UPTAKE
Ferrous iron is generally present in very low quantities in
the body; however, it is more likely to be present in anaerobic conditions or in microaerobic environments at lower
pH which may be relevant in CF lung mucous. A study
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of sputum from 25 CF patients showed that ferrous iron
is abundant in the CF lung and significantly correlates
with disease severity (Hunter et al., 2013). In addition, bacterial and fungal pathogens can convert ferric iron to the
more accessible ferrous form. P. aeruginosa produces
redox-cycling phenazines to achieve this, and the soluble
Fe2+ is transported inside cells via the Feo transport
system composed of a permease FeoB and proteins FeoA
and FeoC (Cartron et al., 2006). Deletion of the feoB
gene results in the inability of P. aeruginosa to form
biofilms and attenuates its virulence (Wang et al., 2011).
Homologues of feoAB have been identified in Staphylococcus spp. and small putative FeoC-like proteins are
encoded within the feo gene cluster in these organisms
(Cartron et al., 2006). The Staphylococcus aureus feoAB(C)
locus is upregulated during iron starvation in a Furdependent manner (Lin et al., 2012; Ledala et al., 2014).
Recently, Mathew et al. (2014) identified a putative iron
uptake locus, ftrBccABCD, in the genome of Burkholderia
cenocepacia H111 that is homologous to a recently
described ferrous uptake system in Bordetella pertussis
and Bordetella abortus (Brickman & Armstrong, 2012),
but it in fact encodes a ferric iron transporter and is not
critical for pathogenicity (Mathew et al., 2014).
Candida albicans has at least 17 ferric reductase genes, and
the ferrireductase CFL1 plays a significant role in filamentous growth and virulence of Candida albicans in a mouse
model of infection (Yu et al., 2014). The reduced iron is
taken into the cell by a complex of an iron permease
with a multicopper oxidase (Knight et al., 2002; Ramanan
& Wang, 2000). Aspergillus fumigatus also uses reductive
iron assimilation involving the ferric reductase FreB to
reduce ferric iron, and ferrous iron is then imported
using a protein complex consisting of the ferroxidase
FetC and the iron permease FtrA (Blatzer et al., 2011).

PATHOGEN INTERACTIONS AND
COMPETITION FOR IRON IN CF
Whilst substantial data exist in relation to the iron acquisition mechanisms of individual CF pathogens, the behaviour of these pathogens in the CF lung and how this
behaviour modulates during chronic infection is critical
to the tackling these infections. In particular, clarifying
the dynamics involved in complex intra- and interspecies
relationships is a challenge. Studies involving transcriptomic and proteomic data from clinical clonal isolates,
real-time quantitative PCR of CF sputa and sequence
analysis of target genes in co-culture systems have
yielded insights into how these pathogens, particularly
P. aeruginosa, behave in the clinical context. In two separate
studies of chronic isolates from CF patients, P. aeruginosa
lost the ability to make pyoverdine, but retained the ability
to take up ferripyoverdine (De Vos et al., 2001; Smith
et al., 2006). A review by Lamont et al. (2009) describes
the multifaceted and adaptive nature of iron acquisition
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by P. aeruginosa in the CF lung. More recently, Martin et al.
(2011) showed that although pyoverdine was detectable in
most P. aeruginosa infected CF sputa, some sputa were
pyoverdine-negative (Martin et al., 2011). Consistent with
these findings, Konings et al. (2013) subsequently demonstrated using real-time quantitative PCR that genes associated with siderophore-mediated iron acquisition including
pyoverdine and pyochelin are expressed at low levels in CF
sputum, and both haem and ferrous iron uptake genes
were also detected, indicating multiple iron uptake pathways
are active but siderophore secretion is downregulated
(Konings et al., 2013). This phenomenon was further
explored by Andersen et al. (2015) in a sequence analysis
study which confirmed that in the CF lung environment,
many P. aeruginosa strains ‘cheat’ by no longer producing
pyoverdine and instead use pyoverdine produced by
co-infecting strains (Andersen et al., 2015). Furthermore,
the functional pyoverdine receptor is lost when pyoverdine
is no longer available – evidence that the P. aeruginosa
pyoverdine system evolves in response to social interactions
(Andersen et al., 2015).
Interactions between P. aeruginosa and other pathogenic
species also have implications for iron acquisition in the
CF lung. An early study by McKenney et al. (1995)
showed that the presence of P. aeruginosa supernatant
enhances siderophore production by Burkholderia cepacia,
indicating that the pathogenesis of Burkholderia cepacia
can be modulated by P. aeruginosa. Consistent with those
data, we have recently demonstrated that pyoverdine from
P. aeruginosa increases the expression of ornibactin synthesis genes by Burkholderia cenocepacia with a concomitant
inhibition of growth (Tyrrell et al., 2015). Conversely,
Weaver & Kolter (2004) demonstrated using microarray
analysis that Burkholderia-conditioned medium and
ornibactin induced genes involved in iron regulation in
P. aeruginosa strains. However, P. aeruginosa is unable to
utilize ornibactin for iron acquisition (Weaver & Kolter,
2004). Bakkal et al. (2010) have reported that bacteriocins
produced by Pseudomonas and Burkholderia strains have
intra- and interspecies bacteriocin-like inhibition ability
within the CF lung (Bakkal et al., 2010). Some of these
bacteriocins, such as the Pseudomonas pyocin, share the
same receptors as siderophores (Denayer et al., 2007;
Elfarash et al., 2014) and therefore interfere with iron
acquisition of their target host. It has also been demonstrated that P. aeruginosa can lyse Staphylococcus aureus
using PqsA, a coenzyme ligase, to gain access to internalized
iron (Mashburn et al., 2005). Staphylococcus aureus,
however, can also compete with P. aeruginosa for free iron
(Mashburn et al., 2005; Harrison et al., 2008). Nguyen &
Oglesby-Sherrouse (2015) recently reported that iron
depletion increases the ability of P. aeruginosa to suppress
the growth of Staphylococcus aureus, and subsequently
Filkins et al. (2015) demonstrated that P. aeruginosa requires
both of its major siderophores to kill Staphylococcus aureus
in a CF bronchial epithelial co-culture model (Filkins et al.,
2015) – all evidence that iron plays a central role in
http://mic.microbiologyresearch.org

modulating interactions between P. aeruginosa and
Staphylococcus aureus in the CF lung. Evidence also suggests
that complex bacterial–fungal interactions occur in the CF
lung. An early report demonstrated that P. aeruginosa
pyocyanin and 1-hydroxyphenazine inhibit the growth of
Aspergillus fumigatus (Kerr et al., 1999). A recent study
confirmed that the inhibition by phenazines was due to
the production of reactive oxygen species, but that the
chelating properties of 1-hydroxyphenazine induced iron
starvation (Briard et al., 2015). An interesting study in the
context of CF lung infection has shown that CF
P. aeruginosa isolates are more inhibitory to Aspergillus
fumigatus growth and biofilm formation than non-CF isolates, and that non-mucoid isolates are the most inhibitory
(Ferreira et al., 2015). Culture filtrates from these isolates
follow the same pattern of inhibition, and notably culture
filtrates from biofilm-grown P. aeruginosa were more
inhibitory to Aspergillus fumigatus biofilms than filtrates
from planktonic cultures (Ferreira et al., 2015) – clear
evidence that adaptive changes in P. aeruginosa growth
impact on the interactions with co-infecting organisms.
There is also evidence that Aspergillus fumigatus responds
to P. aeruginosa exoproducts with the demonstration that
Aspergillus fumigatus metabolizes phenazines secreted by
P. aeruginosa to 1-hydroxyphenazines and that 1-hydroxyphenazine stimulates the secretion of the siderophore triacetylfusarinine C by Aspergillus fumigatus (Moree et al., 2012).
P. aeruginosa phenazines also alter Candida albicans colony
morphology and cellular respiration, and inhibit the growth
and biofilm formation by this fungus, but whether these
effects are due to the chelation properties of phenazines is
unknown (Morales et al., 2013). Further insight into the
interactions between these two pathogens is provided by a
study from Chen et al. (2014) which demonstrates that
P. aeruginosa phenazines induce alcohol production by
Candida albicans which stimulates P. aeruginosa biofilm formation, but also alters the profile of phenazines produced by
P. aeruginosa in favour of those that are most inhibitory
towards Candida albicans. Whether this effect is due to the
chelating properties of phenazines leading to Candida
albicans iron starvation has not been established; however,
given the effect of phenazines on the iron homeostasis of
Aspergillus fumigatus (Briard et al., 2015), it is likely that it
is at least a contributing factor. Taken together, these reports
highlight the complexity of interspecies competition for
iron and survival in the CF lung, and possible mechanisms
by which P. aeruginosa dominates in this environment.

NOVEL THERAPEUTIC STRATEGIES
TARGETING IRON ACQUISITION IN CF
PATHOGENS
The absolute requirement for iron by CF pathogens has led
to investigations of iron chelation therapy in an effort to
limit its availability and compromise pathogen growth
and survival in the host. Moreau-Marquis et al. (2008)
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demonstrated reduced P. aeruginosa biofilm growth on
epithelial cells treated with an iron chelator and subsequently demonstrated (Moreau-Marquis et al., 2009)
tobramycin in combination with iron chelators can eliminate P. aeruginosa biofilms. In a recent study, the same
group have shown that a combination of hypocyanite
and lactoferrin enhances the ability of tobramycin and
aztreonam to eliminate P. aeruginosa biofilms on lung
epithelial cells (Moreau-Marquis et al., 2015). Data from
Reid et al. (2009) indicate that iron chelation enhances
the efficacy of tobramycin therapy in a low oxygen environment, such as that which pertains in areas of the CF lung.
Taken together, these data provide strong evidence for iron
chelation to be an effective adjunctive therapy in treating
P. aeruginosa lung infections. Treatment with the host
iron-binding protein lactoferrin reduces both the epithelial
invasion of Burkholderia cenocepacia and the inflammatory
response of CF bronchial epithelial cells to Burkholderia
cenocepacia biofilm (Berlutti et al., 2008). Whether these
effects are the result of iron chelation or an alternative
mechanism is unknown. Lactoferrin has been shown to
interact with the cable pilus of Burkholderia cenocepacia
(Ammendolia et al., 2010), which may interfere with cell
attachment. The iron chelator desferasirox in combination
with liposomal amphotericin B in a murine model of invasive aspergillosis resulted in a significant decrease in fungal
burden and enhanced survival compared with placebotreated mice (Ibrahim et al., 2010). However, other
dual- and triple-therapy combinations with desferasirox
worsened outcomes (Ibrahim et al., 2011). Therefore, it
as yet unclear whether combining iron chelators with conventional antifungals will have any future in the clinical
treatment of invasive aspergillosis.
Despite the multifaceted capacity for iron acquisition
demonstrated by all of the main CF pathogens (summarized
in Table 1) and the redundancy of their iron-scavenging systems, targeting siderophore-mediated iron uptake systems
has proven to have significant potential as a bacteriostatic
or antimicrobial strategy. One approach is the inhibition
of the catalytic mechanisms of siderophore biosynthesis.
Non-ribosomal protein synthetase (NRPS) enzymes have
no human homologues and the catalytic mechanisms
involved in the biosynthesis of many siderophores have
been characterized, which facilitates the targeting of siderophore biosynthesis as a therapeutic strategy. Imperi et al.
(2013) screened a library of bioactive compounds for
pyoverdine-inhibitory compounds. A compound, flucytosine, which inhibits PvdS, a promoter of virulence
genes including pyoverdine synthesis genes, was identified
and flucytosine reduced P. aeruginosa pathogenicity in
a mouse model (Imperi et al., 2013). Baulamycin A,
a broad-spectrum antibiotic produced by a Streptomyces
spp., acts as a competitive inhibitor of the Staphylococcus
aureus SbnE synthetase, involved in the NRPS-independent
synthesis of staphyloferrin B, and impedes the growth of
Staphylococcus aureus under iron restriction (Tripathi
et al., 2014). This report demonstrates the enormous
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potential of targeting siderophore biosynthesis pathways
using these natural baulamycins, which can be further
modified to enhance efficacy and specificity. Inhibitors of
siderophore biosynthesis targeting both NRPS enzymes
and those involved in NRPS-independent pathways of siderophore biosynthesis have been extensively reviewed by
Lamb (2015). An alternative approach has been the genetic
engineering of the NRPSs to synthesize novel siderophores–
a strategy which has been applied to the production of novel
pyoverdines (Calcott & Ackerley, 2014; Calcott et al., 2014).
In addition to targeting siderophore iron acquisition, the
inhibition of the final step in liberating iron from haem
has also been investigated. Using a computer-aided drug
design approach, inhibitors that bind to the haem pocket
of the HemO enzyme have been identified, and shown to
have in vitro activity against P. aeruginosa clinical isolates
and in vivo activity in the Caenorhabditis elegans host–
pathogen model of infection (Hom et al., 2013).
There are no licensed vaccines currently available for any of
the CF pathogens discussed above. Attempts have been
made to develop vaccines based on iron acquisition receptors, although success to date has been limited and only
those targeting Staphylococcus aureus have reached clinical
trials. A vaccine against the Staphylococcus aureus haemoglobin receptor IsdB, V710, generated promising data
from phase I and IIa trials; however, a lack of efficacy and
safety concerns emerged in a subsequent trial (Fowler
et al., 2013). In a recent study, vaccination with a threecomponent vaccine including antigenic regions of IsdB
reduced bacterial load and increased survival in a murine
model of Staphylococcus aureus infection (Delfani et al.,
2015). Another vaccine based on the ferric hydroxamate
receptor FhuD2 only offered partial protection against
staphylococcal infection in murine models (Mishra et al.,
2012; Mariotti et al., 2013).
One of the most successful therapeutic approaches to date
involving bacterial iron acquisition systems has been the
exploitation of these pathways to deliver antibiotic–siderophore conjugates to target cells. This concept is based on
the naturally occurring sideromycin antibiotics that
mimic siderophores to gain intracellular access (Braun
et al., 2009). Over the past three decades, numerous conjugates linking a siderophore or a siderophore mimic to
different antibiotics via a linker molecule have been synthesized with varying degrees of antimicrobial efficacy
(Möllmann et al., 2009; Wencewicz et al., 2009; Zeng et al.,
2012; Fardeau et al., 2014). This approach, known as the
‘Trojan horse’ strategy, has been the subject of several reviews
(including those by de Carvalho & Fernandes, 2014;
Górska et al., 2014; Mislin & Schalk, 2014). Challenges to
the design of these conjugates include optimal linker
design to avoid interference with siderophore receptor binding and the development of resistance due to the loss of
components of the siderophore uptake system (Minnick
et al., 1992). Competition with native siderophores was
also reported in a recent mouse model of P. aeruginosa infection treated with a siderophore-conjugated monobactam
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(Tomaras et al., 2013). A recent siderophore sulfactam
conjugate BAL20072 developed by Basilea Pharmaceutic
has shown significant promise against multidrug-resistant
Gram-negative isolates including P. aeruginosa and Bcc
spp. (Page et al., 2010; Hofer et al., 2013; Landman et al.,
2014), and is currently in phase 1 clinical trials. Another
promising conjugate in development is S-649266 from
Shionigi, which is a catechol-substituted siderophore
conjugated to cephalosporin with significant activity against
multidrug-resistant Gram-negatives including P. aeruginosa.
Phase II trials of this drug are currently under way (ClinicalTrials.gov ID: NCT02321800). In addition to antimicrobial
siderophore conjugates, haem uptake systems also have
the potential to be targeted with antibiotic–porphyrin
conjugates (Stojiljkovic et al., 2001). Natural and synthetic
porphyrins exhibit a range of light-dependent and lightindependent antibacterial activities, exhibit low toxicity
in vivo, and are amenable to chemical modification,
making them ideal compounds for targeting microbial
pathogens (Stojiljkovic et al., 1999). Given the increasing literature on the structures and pathways involved in bacterial
iron acquisition, it is becoming more likely that a successful
synthetic analogue drug delivered to the cell via an iron
uptake mechanism will eventually come to market.
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Iron acquisition is a multifaceted and dynamic process for
CF pathogens which is essential for colonization and infection in the competitive environment of the CF lung.
Siderophore-mediated iron uptake is an important
component of this process, with the most prominent CF
pathogen, P. aeruginosa, capable of extensive siderophore
piracy. The deployment of alternative iron acquisition
systems, including the uptake of ferrous iron and the scavenging of iron from host iron acquisition proteins, further
enhances the ability of pathogens to establish infection and
poses additional challenges to targeting iron acquisition as
a therapeutic strategy. Nonetheless, the urgent need to
combat antibiotic-resistant lung infections has led to a
renewed focus on novel approaches to this problem and
iron acquisition pathways remain in the spotlight.
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Sideromycins: tools and antibiotics. Biometals 22, 3–13.
Briard, B., Bomme, P., Lechner, B. E., Mislin, G. L., Lair, V., Prévost, M. C.,
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Vandenbroucke-Grauls, C. & Bitter, W. (2006). The heterologous

Minnick, A. A., McKee, J. A., Dolence, E. K. & Miller, M. J. (1992).

Iron transport-mediated antibacterial activity of and development
of resistance to hydroxamate and catechol siderophorecarbacephalosporin conjugates. Antimicrob Agents Chemother 36,
840–850.

siderophores ferrioxamine B and ferrichrome activate signaling
pathways in Pseudomonas aeruginosa. J Bacteriol 188, 1882–1891.

Mishra, R. P., Mariotti, P., Fiaschi, L., Nosari, S., Maccari, S.,
Liberatori, S., Fontana, M. R., Pezzicoli, A., De Falco, M. G. & other
authors (2012). Staphylococcus aureus FhuD2 is involved in the

Llamas, M. A., Mooij, M. J., Sparrius, M., Vandenbroucke-Grauls,
C. M., Ratledge, C. & Bitter, W. (2008). Characterization of five

early phase of staphylococcal dissemination and generates protective
immunity in mice. J Infect Dis 206, 1041–1049.

novel Pseudomonas aeruginosa cell-surface signalling systems. Mol
Microbiol 67, 458–472.
Lubamba, B., Dhooghe, B., Noel, S. & Leal, T. (2012). Cystic fibrosis:

Mislin, G. L. & Schalk, I. J. (2014). Siderophore-dependent iron uptake
systems as gates for antibiotic Trojan horse strategies against
Pseudomonas aeruginosa. Metallomics 6, 408–420.

insight into CFTR pathophysiology and pharmacotherapy. Clin
Biochem 45, 1132–1144.
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